Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record now presents details for a Phase 1b study of GMI-1359 in people with HR+ metastatic breast cancer, including its study design, participant criteria, and measured outcomes. It states that the trial was terminated after COVID-related slow enrollment and is no longer recruiting.
    Difference
    39%
    Check dated 2026-11-10T06:57:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible because the page displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T06:17:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces updates to the NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The study record continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-27T06:40:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The 403 Forbidden page remains unchanged, while its footer revision updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T06:58:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T08:14:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error screen, preventing access to the study details. The usual page content and navigation are replaced by the error UI, indicating an access restriction rather than actual study information.
    Difference
    16%
    Check dated 2026-09-22T06:37:03.000Z thumbnail image

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.